Antidepressant combinations:: epidemiological considerations

被引:4
作者
Agüera, LF
Rojo, JE
Ros, S
de la Gándara, J
de Pedro, JM
机构
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ Bellvitge, Hosp Llobregat, Bellvitge, Spain
[3] Hosp del Mar, Barcelona, Spain
[4] Hosp Gen Yague, Burgos, Spain
[5] Organon Spain SA, Dept Med, Barcelona, Spain
关键词
antidepressants; drug combinations; epidemiology; depression;
D O I
10.1111/j.1600-0447.2005.00674.x
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
Objective: To evaluate the treatment options in patients who do not respond appropriately to a single antidepressant alone. Method: The medical literature was reviewed. Results: A number of strategies are available if a patient fails to respond adequately to initial antidepressant treatment, including the combination with another psychoactive drug. Evidence published to date appears to suggest that benzodiazepines are the drugs most frequently combined with antidepressants. The combination of two antidepressants together is less common, occurring in approximately 5-15% of cases showing a poor initial response. The key figures involved in such co-prescription are psychiatrists. Conclusion: There appears to be considerable variability in the data concerning combined prescription of antidepressants, with differences arising depending on the type of physician, the type of patient or illness and the geographical area. It is also unclear how closely research findings parallel with what doctors do in everyday practice.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 15 条
[1]
Agüera-Ortiz LE, 2000, ACTAS ESP PSIQUIATRI, V28, P343
[2]
Which patients receive antidepressants? A 'real world' telephone study [J].
Bouhassira, M ;
Allicar, MP ;
Blachier, C ;
Nouveau, A ;
Rouillon, F .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (01) :19-26
[3]
Mirtazapine augmentation in the treatment of refractory depression [J].
Carpenter, LL ;
Jocic, Z ;
Hall, JM ;
Rasmussen, SA ;
Price, LH .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (01) :45-+
[4]
Coryell W, 2000, Ann Clin Psychiatry, V12, P141, DOI 10.1023/A:1009012917837
[5]
Antidepressant drug use: Differences between psychiatrists and general practitioners - Results from a drug utilization observation study with fluoxetine [J].
Dittmann, RW ;
Linden, M ;
Osterheider, M ;
Schaaf, B ;
Ohnmacht, U ;
Weber, HJ .
PHARMACOPSYCHIATRY, 1997, 30 :28-34
[6]
Antidepressant augmentation and combinations [J].
Dording, CM .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 23 (04) :743-+
[7]
Fava M, 2000, J CLIN PSYCHIAT, V61, P26
[8]
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current "next-step" practices [J].
Fredman, SJ ;
Fava, M ;
Kienke, AS ;
White, CN ;
Nierenberg, AA ;
Rosenbaum, JF .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (06) :403-408
[9]
Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it? [J].
McManus, P ;
Mant, A ;
Mitchell, P ;
Birkett, D ;
Dudley, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (01) :93-98
[10]
Nelson JC, 2000, J CLIN PSYCHIAT, V61, P13